Recent Breakthroughs in Alzheimer's Treatment

This chapter explores the latest breakthroughs in Alzheimer’s treatment, focusing on the newly approved drugs licanumab and donanumab that slow disease progression. It covers their mechanism of action, administration methods, and the significant implications for millions affected by Alzheimer’s, along with future drug development insights.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app